IMCD Buys Indian Distributor Indchem for Pharma business

By Gareth Macdonald

- Last updated on GMT

Related tags: Pharmacology, Active ingredient

IMCD buys India's Indcehm
IMCD buys India's Indcehm
Chemical distributor IMCD Group says acquisition of Mumbai-based Indchem will build its presence in the Indian pharmaceutical excipient sector.

The takeover deal – financial terms of which were not disclosed – saw Indchem merge with the Netherlands-headquartered chemical firm’s local division, IMCD India, and former owner Narayan Sainathan appointed as head of that organization’s pharmaceutical business unit.

IMCD spokeswoman Marina Kaptein told that: “For India, we were keen to establish ourselves in this sector too and hence the acquisition of Indchem​,” explaining that “Indchem is a key player in the excipient market and ranks in Top 5 in the distribution industry​.”

Indchem is focused on the supply of excipients to the pharmaceutical industry in India, including those used in solid dosage forms, liquids, topicals and parenterals. It also provides compounds used in modified-release delivery technologies, patches and dry powder inhalers. 

The firm markets and locally distributes excipients made by a number of non-Indian suppliers like Amitec Corp and SPI Pharma from the US and Germany’s DFE Pharma and positions itself as “as an extended arm​” of such companies.

This approach fits with IMCD’s business according to Kaptein, who said: “Our key strengths are in having technical background and working with customers to bring innovative products to their needs whilst providing first class service and supply chain solutions to the market.​”

The takeover comes just a few months after IMCD bought the pharmaceutical ingredients business of Malaysian ingredient and excipient distributor Maxwell Pharma. It also follows a little over a year after the Netherlands firm bought Italian fine chemicals supplier Organotec​.

These deals, coupled with the acquisition of South Africa’s chemicals and formulation supplier Ethnichem in summer 2011 and the Indchem takeover, underline IMCD’s desire to establish a bigger presence in the pharmaceutical industry according to business director Ashvin Patel.

With Indchem’s excellent customer service and technical support on board, IMCD will be able to further strengthen our presences on the Indian market​.”

Related news

Show more

Related product

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Follow us


View more